Insulin‐like growth factor binding protein‐4: The quest for the breakthrough biomarker in pulmonary arterial hypertension

Energy metabolism pathways and their association with cell proliferation and growth have been related to PAH, in particular the insulin-like growth factor (IGF) axis pathways. High-throughput plasma proteome analysis in PAH patients has identified proteins that correlate to survival, identifying the...

Full description

Saved in:
Bibliographic Details
Published inPulmonary circulation Vol. 13; no. 2; pp. e12252 - n/a
Main Authors Estrada, Rodolfo A., Sahay, Sandeep
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.04.2023
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Energy metabolism pathways and their association with cell proliferation and growth have been related to PAH, in particular the insulin-like growth factor (IGF) axis pathways. High-throughput plasma proteome analysis in PAH patients has identified proteins that correlate to survival, identifying the insulin-growth factor binding protein-1 (IGFBP-1) as one of them. Subgroup analysis revealed that regardless of PAH subtype, above median IGFBP-4 levels were associated with worsening survival rates. Sandeep Sahay: Grants/Research Support: Research grant from United Therapeutics; Consultant: United Therapeutics, J&J, Bayer, Gossamer Bio, Liquidia technologies, Keros; Speaker's Bureau: Janssen, United Therapeutics (honorarium received by Houston Methodist Hospital Foundation); Clinical trial support from United Therapeutics, Janssen, Gossamer Bio, Altavant Sciences, Liquidia technologies, Novartis, Keros.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:2045-8940
2045-8932
2045-8940
DOI:10.1002/pul2.12252